New York attorney general charges former Emergent BioSolutions chief with insider trading
Robert G Kramer is accused of selling his company shares before publicly revealing contamination issues with his company’s COVID-19 vaccine production.
Robert G Kramer is accused of selling his company shares before publicly revealing contamination issues with his company’s COVID-19 vaccine production.
New rules are an attempt to set industry standards and to protect consumers.
The platform failed to comply with required New York laws for trading digital assets.